From a7eba727ce9cb2cf16c12dfe42b16c4a5a21fff5 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Wed, 17 Jan 2024 11:09:08 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Viaje a Ghana 2023.md | 3 ++- 1 file changed, 2 insertions(+), 1 deletion(-) diff --git a/pages/STOP2030___Viaje a Ghana 2023.md b/pages/STOP2030___Viaje a Ghana 2023.md index 37734734..61d6d54f 100644 --- a/pages/STOP2030___Viaje a Ghana 2023.md +++ b/pages/STOP2030___Viaje a Ghana 2023.md @@ -30,4 +30,5 @@ date:: [[2023/12]] - Good Clinical Practice (can be GFDA or from different organization as long as not expired) - Reference lab - Samples should be run on site (Kato Katz in the schools) and others in-country (ELISA dried blood spots for Strongyloides), with a lab in Accra still to be identified. - - Communication & Social mobilization - NTD \ No newline at end of file + - Communication & Social mobilization - NTD Programme/RDD/Health Promotion/Mundo Sano + - Frame messaging on why doing clinical trial as based on Trichuris burden – evidence for clinical trial most clear as albendazole is less effective and we have decent burden data; Reinforce messaging that will be a \ No newline at end of file